December 10, 2021

Prescription Drug Importation Policies: Politically Popular, But Problematic for Public Health

In the National Association of Boards of Pharmacy’s (NABP) Innovations publication, government and regulatory affairs advisor Nisha Quasba coauthored an article on the concerns with any plan to bring drugs into the U.S. that would bypass America’s highly regulated drug supply chain.

First, Quasba addresses drug supply chain security. She explains that drug importation — even if intended to be for wholesale and not for personal use — can directly or indirectly drive unknowing consumers to the internet, where NABP has found that 96% of online “pharmacies” are operating illegally, with many falsely claiming to be based in Canada.

Quasba further outlines recent policy ideas related to drug importation in the Biden administration and Congress. In conclusion, she emphasizes the NABP’s focus on public health safety.

Full Article


Photo of Nisha Quasba
Nisha K. Quasba

Senior Manager - Health Policy & Government Relations

Related Legal Services

Related Policy, Advocacy, and Consulting Services

Related Industries

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.